StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Assembly Biosciences's price to book ratio was 1.5× on Nov 11, 2026, against 3.3× a year earlier. Over the last 5 years it ranged from 0.4× to 13.2×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−1.5
2025Dec 31, 20252.9×−0.9
2024Dec 31, 20243.9×+2.8
2023Dec 29, 20231.0×+0.4
2022Dec 30, 20220.6×+0.1
2021Dec 31, 20210.5×−0.2
2020Dec 31, 20200.7×−2.6
2019Dec 31, 20193.4×+0.9
2018Dec 31, 20182.5×−14.2
2017Dec 29, 201716.7×+14.4
2016Dec 30, 20162.3×+1.3
2015Dec 31, 20151.0×−0.4
2014Dec 31, 20141.4×−1.2
2013Dec 31, 20132.6×+1.3
2012Dec 31, 20121.3×−0.6
2011Dec 30, 20111.9×–

More Assembly Biosciences figures

See a number that looks wrong?